RESULTS	In a double-blind , multicenter trial , 170 patients hospitalized for worsening heart failure and given standard therapy were randomly assigned to treatment with conivaptan ( 20-mg loading dose followed by 2 successive 24-hour continuous infusions of 40 , 80 , or 120 mg/d ) or placebo .\